MDB Capital Holdings Provides Second Quarter 2026 Update
Rhea-AI Summary
MDB Capital Holdings (NASDAQ: MDBH) reported operational highlights for the first six months of 2026, including serving as sole bookrunner and underwriter on the $20 million BUDA Juice IPO, joint bookrunner on the $15 million Ticketplus IPO, and completing a $5.9 million public offering for eXoZymes (NASDAQ: EXOZ).
MDB expanded its pipeline of early-stage disruptive companies, advanced discussions with potential MDB Direct/Public Ventures strategic partners, and prepared a spin-out of PatentVest as an independent public company. For the first half of 2026, MDB reported a net loss of approximately $16.1 million, fixed operating expenses of about $5 million, net cash used of about $3 million, and roughly $12.1 million in cash, current assets and marketable securities net of liabilities. Management will host a Zoom webinar on August 13, 2026, at 4:30 p.m. ET.
Positive
- $20 million BUDA Juice IPO as sole bookrunner and underwriter
- Joint bookrunner role on Ticketplus IPO of $15 million
- Completed $5.9 million public offering for eXoZymes
- Fixed operating expenses flat at approximately $5 million
- Net cash used limited to approximately $3 million in six months
- Cash, current assets and marketable securities net of liabilities about $12.1 million
Negative
- First half 2026 net loss of approximately $16.1 million
- Operating net loss, dilution and small impairment in eXoZymes about $4.4 million
- Non-cash loss on investment securities approximately $5 million
- Non-cash stock-based compensation expense booked at about $5 million
News Explained
The
News Market Reaction – EXOZ
In the Aug 14 session, EXOZ declined 3.00%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 11 | Conference call notice | Neutral | +0.0% | Second-quarter update conference call was scheduled for August 20 |
| Jul 23 | AI program selection | Positive | +0.2% | Selected for DOE Genesis Mission AI initiative with $147,000 company award |
| Jun 24 | NIH grant award | Positive | +3.6% | Received $2,028,518 non-dilutive Phase IIB SBIR grant |
| Jun 17 | Public offering closing | Negative | +23.7% | Closed public offering generating approximately $5.95 million gross proceeds |
| Jun 08 | Offering pricing | Negative | -7.7% | Priced common-stock and warrant unit offering for approximately $5.33 million |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical offering-related news produced mixed reactions, with one positive divergence and one negative alignment.
Key Terms
ipo financial
bookrunner financial
underwriter financial
stock-based compensation financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management to Host Conference Call Today at 4:30 p.m. ET
Addison, TX, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, provides a business update for the quarter ended June 30, 2026, and subsequent developments.
First Six Months of 2026 and Subsequent Operational Highlights
- Completed
$20 million IPO for Buda Juice (NYSE American: BUDA) as the sole bookrunner and underwriter, our 18th consecutive successful IPO.
- Partnered with Roth Capital Partners and Bancroft Capital as joint bookrunners for the
$15 million Ticketplus IPO (NYSE American; TP). - Completed underwriting of
$5.9 million public offering for eXoZymes (Nasdaq: EXOZ), advancing the AI-enabled cell-free biomanufacturing platform. - Expanded our pipeline of early-stage, disruptive companies capable of becoming leaders in new categories.
- Advanced discussions with potential MDB Direct/Public Ventures strategic partners to significantly expand distribution of our offerings and monetize this valuable asset.
- Advanced preparations to spin-out PatentVest, our AI-Native IP law firm, to become an independent public company, further leveraging this unique asset to create value for MDB.
- Completed upgrade of MDB Direct clearing and trading platform to BetaNXT, a leading financial technology platform specializing in trading, settlement and wealth management, to deliver greater security, efficiency and future capabilities to our investors.
- Broadened relationships with Family Offices, RIAs and private wealth managers to reach new investors with large equity portfolios looking for new strategies to gain venture exposure.
First Six Months of 2026 Financial Results
- Reported a net loss of approximately
$16.1 million of which:
-
- Approximately
$4.4 million in operating net loss, dilution and a small impairment in our equity investment in eXoZymes. - Approximately
$5 million non-cash loss related to the value in investment securities held. - Approximately
$5 million in booked expense of non-cash stock-based compensation valued in 2022.
- Approximately
- Fixed operating expenses remained flat at approximately
$5 million , which includes approximately$2 million investment in MDB Direct/Public Ventures clearing platform and PatentVest subsidiaries. - Net cash used of approximately
$3 million . - Approximately
$12.1 million held in cash, current assets, and marketable securities less all liabilities.
Second Quarter 2026 Update Zoom Webinar at 4:30 p.m. ET Today
Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments and ongoing initiatives as well as host a question-and-answer period.
Investors can pre-register now for the Zoom webinar HERE. The live webinar can also be accessed on the day of the event through MDB’s investor relations website at https://investors.mdb.com/ .
About MDB Capital Holdings, LLC
Every new category starts with a leader willing to build it and a story compelling enough for the market to believe. Since1997, MDB Capital has partnered with those founders, curating the breakthroughs, shaping the narrative, and launching them on the public markets before a traditional IPO would allow. Our public venture platform is purpose-built to enable breakthroughs reach the public markets and society sooner, and enable investors get in earlier on the companies defining what comes next — capturing asymmetric upside with public market liquidity. MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries—including MDB Capital, a venture-focused broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm—operate under the MDB Capital brand. MDB Capital is a registered broker-dealer, Member FINRA/SIPC. For more information, please visit www.mdb.com.
Forward-Looking Statements
This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.
Investor Relations Contact:
IR@mdb.com
Media Contact:
press@mdb.com
